Ataxia telangiectasia gene mutations in leukaemia and lymphoma.
Ataxia telangiectasia (AT) is a rare multisystem, autosomal, recessive disease characterised by neuronal degeneration, genome instability, and an increased risk of cancer. Approximately 10% of AT homozygotes develop cancer, mostly of the lymphoid system. Lymphoid malignancies in patients with AT are...
Príomhchruthaitheoir: | Boultwood, J |
---|---|
Formáid: | Journal article |
Teanga: | English |
Foilsithe / Cruthaithe: |
2001
|
Míreanna comhchosúla
Míreanna comhchosúla
-
MEK inhibitors block growth of lung tumors with mutations in Ataxia Telangiectasia Mutated
de réir: Smida, M, et al.
Foilsithe / Cruthaithe: (2016) -
Phenotypic consequences of somatic mutations in the ataxia-telangiectasia mutated gene in non-small cell lung cancer
de réir: Weber, A, et al.
Foilsithe / Cruthaithe: (2016) -
The role of declining ataxia-telangiectasia-mutated (ATM) function in oocyte aging
de réir: Suzuki, R, et al.
Foilsithe / Cruthaithe: (2024) -
Risk of breast cancer and other cancers in heterozygotes for ataxia-telangiectasia.
de réir: Inskip, H, et al.
Foilsithe / Cruthaithe: (1999) -
Odalisque's position as a geste antagoniste in a variant phenotype of ataxia-telangiectasia
de réir: Barrea, C, et al.
Foilsithe / Cruthaithe: (2019)